STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: A replication study

被引:24
|
作者
Marcela Diaz-Gallo, Lina [1 ]
Palomino-Morales, Rogelio J. [1 ]
Gomez-Garcia, Maria [2 ]
Cardena, Carlos [3 ]
Rodrigo, Luis [4 ]
Nieto, Antonio [5 ]
Alcain, Guillermo [6 ]
Cueto, Ignacio [6 ]
Lopez-Nevot, Miguel A. [7 ]
Martin, Javier [1 ]
机构
[1] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain
[2] Hosp Univ Virgen Nieves, Serv Digest, Granada, Spain
[3] Hosp Clin San Cecilio, Serv Digest, Granada, Spain
[4] Hosp Univ Cent Asturias, Serv Digest, Oviedo, Spain
[5] Hosp Puerta Mar, Serv Inmunol, Cadiz, Spain
[6] Hosp Virgen Victoria, Serv Digest, Malaga, Spain
[7] Hosp Univ Virgen Nieves, Serv Inmunol, Granada, Spain
关键词
Signal transducer and activator of transcription 4 (STAT4) gene; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Genetic association study; INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; ASSOCIATION; RISK; POLYMORPHISMS; PATHOGENESIS; CLASSIFICATION; SUSCEPTIBILITY; METAANALYSIS;
D O I
10.1016/j.humimm.2010.02.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recently, the signal transducer and activator of transcription 4 (STAT4) gene has been associated with multiple autoimmune diseases. Interestingly, a recent work showed that the T allele of the rs7574865 STAT4 SNP was associated with inflammatory bowel disease (IBD) in a Spanish population. The aim of the present study was to reevaluate the role of the STAT4 rs7574865 polymorphism on IBD. The present case-control study included 498 Crohn's disease (CD) patients, 402 ulcerative colitis (DC) patients, and 1296 healthy matched controls. Genotyping was performed using a PCR system with a pre-developed TaqMan allelic discrimination assay for the rs7574865 STAT4 SNP. Moreover, a meta-analysis was performed with the previous work in a Spanish population and the current study, including a final sample size of 1574 IBD patients (820 with CD and 754 with UC) and 2012 healthy controls. No evidence of association was found for the current case-control study (CD: p = 0.23, OR = 0.9,95% CI = 0.75-1.1; UC: p = 0.17, OR = 1.14, 95% CI = 0.95-1.38). However, the meta-analysis showed that the STAT4 rs7574865 T allele was significantly associated with susceptibility to UC (p = 0.012 pooled; OR = 1.20, 95% CI = 1.04-1.39) but not CD (p = 0.71 pooled; OR = 0.93, 95% CI = 0.65-1.34). Our data suggest that the rs7574865 STAT4 SNP is a genetic susceptibility variant for DC but not CD in the Spanish population. (C) 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:515 / 519
页数:5
相关论文
共 50 条
  • [31] Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD)
    Bouma, G
    Pool, MO
    Crusius, JBA
    Schreuder, GMT
    Hellemans, HPR
    Meijer, BUGA
    Kostense, PJ
    Giphart, MJ
    Meuwissen, SGM
    Pena, AS
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 175 - 179
  • [32] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients
    Barreiro-de Acosta, Manuel
    Marin-Jimenez, Ignacio
    Panadero, Abel
    Guardiola, Jordi
    Canas, Mercedes
    Gobbo Montoya, Milena
    Modino, Yolanda
    Alcain, Guillermo
    Maia Bosca-Watts, Marta
    Calvet, Xavier
    Casellas, Francesc
    Chaparro, Maria
    Fernandez Salazar, Luis
    Ferreiro-Iglesias, Rocio
    Ginard, Daniel
    Iborra, Marisa
    Mancenido, Noemi
    Manosa, Miriam
    Merino, Olga
    Rivero, Montserrat
    Roncero, Oscar
    Sempere, Laura
    Vega, Pablo
    Zabana, Yamile
    Minguez, Miguel
    Nos, Pilar
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2018, 41 (02): : 118 - 127
  • [33] Evidence for Stat4 as a Common Autoimmune Gene: Rs7574865 is Associated With Colonic Crohn's Disease and Early Disease Onset
    Diegelmann, Julia
    Glas, Jurgen
    Seiderer, Julia
    Nagy, Melinda
    Beigel, Florian
    Pfennig, Simone
    Goke, Burkhard
    Ochsenkuhn, Thomas
    Brand, Stephan
    GASTROENTEROLOGY, 2010, 138 (05) : S684 - S684
  • [34] POLYGENIC RISK SCORE INDEPENDENTLY INFLUENCES PSC RISK IN ULCERATIVE COLITIS BUT NOT CROHN'S DISEASE
    Wang, Ming-Hsi
    Friton, Jessica J.
    Raffals, Laura H.
    Leighton, Jonathan A.
    Newberry, Rodney D.
    Faubion, William
    GASTROENTEROLOGY, 2022, 162 (07) : S631 - S632
  • [35] Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn's disease
    Cherry, Lauren N.
    Yunker, Nancy S.
    Lambert, Erika R.
    Vaughan, DaleMarie
    Lowe, Denise K.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2015, 6 (05) : 224 - 233
  • [36] Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment
    Barreiro-de Acosta, Manuel
    Marin-Jimenez, Ignacio
    Rodriguez-Lago, Iago
    Guarner, Francisco
    Espin, Eloy
    Ferrer Bradley, Isabel
    Gutierrez, Ana
    Beltran, Belen
    Chaparro, Maria
    Gisbert, Javier P.
    Nos, Pilar
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (10): : 649 - 658
  • [37] Distinct and Overlapping Genetic Loci in Crohn's Disease and Ulcerative Colitis: Correlations with Pathogenesis
    Waterman, Matti
    Xu, Wei
    Stempak, Joanne M.
    Milgrom, Raquel
    Bernstein, Charles N.
    Griffiths, Anne M.
    Greenberg, Gordon R.
    Steinhart, A. Hillary
    Silverberg, Mark S.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (09) : 1936 - 1942
  • [38] Octn variants: Evidence for genetic association with both Crohn's disease and ulcerative colitis
    Waller, S
    Tremelling, M
    Bredin, F
    Godfrey, L
    Hunter, J
    Middleton, S
    Woodward, J
    Howson, J
    Parkes, M
    GASTROENTEROLOGY, 2005, 128 (04) : A447 - A447
  • [39] Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
    Rosario, M.
    Dirks, N. L.
    Gastonguay, M. R.
    Fasanmade, A. A.
    Wyant, T.
    Parikh, A.
    Sandborn, W. J.
    Feagan, B. G.
    Reinisch, W.
    Fox, I.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (02) : 188 - 202
  • [40] DISEASE DURATION IMPACTS INTESTINAL GENE EXPRESSION PROFILES IN CROHN'S DISEASE BUT NOT IN ULCERATIVE COLITIS
    Ibing, Susanne
    Tastad, Christopher
    Renard, Bernhard Y.
    Argmann, Carmen A.
    Sands, Bruce E.
    Dubinsky, Marla C.
    Suarez-Farinas, Mayte
    Colombel, Jean Frederic
    Bottinger, Erwin P.
    Cho, Judy H.
    Petralia, Francesca
    Ungaro, Ryan C.
    GASTROENTEROLOGY, 2024, 166 (05) : S1414 - S1414